WASHINGTON, April 22 -- Sen. Elizabeth Warren issued the following press release:
At a hearing of the Senate Finance Committee, U.S. Senator Elizabeth Warren (D-Mass.) pressed Secretary of Health and Human Services (HHS) Robert F. Kennedy Jr. on TrumpRx, revealing how President Trump's marquee drug pricing effort often provides higher prices for Americans while boosting Big Pharma's bottom line.
Following the Trump Administration's efforts to cut health care for millions of Americans, TrumpRx launched as a direct-to-consumer platform where Americans can purchase brand-name drugs for a cash price outside of insurance. President Trump has stated that TrumpRx has reduced prices by as much as 600%, which Senator Warren noted would "mean compa...